Header graphic for print
Focus on Regulation

Tag Archives: legislation

Border Adjustability Tax in Peril?

The future of the Border Adjustment Tax (BAT) proposal, a critical element of the House Republican tax reform plan, is in doubt after signs of Republican opposition in the Senate emerged last week. Senator David Perdue (R-GA) became the most prominent Republican to overtly criticize the BAT, expressed in a Dear Colleague letter to his

Congress Agrees on Six-Year Reauthorization of Terrorism Risk Insurance Act (TRIA)

After failing to pass a TRIA reauthorization during the lame duck session last Congress, on January 7, 2015, the House passed H.R. 26, the Terrorism Risk Insurance Program Reauthorization Act of 2015, by a vote of 416-5. Shortly after on January 8, 2015, the Senate passed H.R. 26 by a 93-4 vote. Upon the President’s signature, TRIA will be reauthorized until December 31, 2020.

114th Congress Outlook

Twenty years ago, two years after the first inauguration of President Clinton, Republicans took control of both houses of Congress for the first time since 1953. Despite significant disagreements between Clinton and the Republican-controlled Congress, that period of 1995 through 2000 was a relatively productive one for the U.S. Congress, producing welfare reform, several tax bills, a balanced budget agreement, significant telecommunications legislation, and many other laws.

Winnik Forum: Drafting Legislation for the Internet of Things

One of the challenges facing regulators as they craft rules to govern the Internet of Things is that traditional industry silos that were the basis for past legislation may no longer apply.  As part of the 2014 Winnik Forum, Hogan Lovells’ partners Michele Farquhar and Trey Hanbury joined two senior staff members from the U.S.

Compromise Legislative Proposal on Regulation of Compounding Pharmacies Released

Last evening, House and Senate staff released a new legislative proposal that reflects their negotiated agreement on how to clarify the Food and Drug Administration’s (FDA) authority to regulate compounding pharmacies. The legislation will resolve the 1st Amendment and severability issues relating to section 503A of the Food, Drug and Cosmetic Act.  These issues have